Faron Pharmaceuticals Oy (AIM:FARN)
London
· Delayed Price · Currency is GBP · Price in GBX 51.50
-2.00 (-3.74%)
Mar 9, 2026, 1:13 PM GMT
Faron Pharmaceuticals Oy Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 12.32 | 9.5 | 6.88 | 6.99 | 6.85 | Upgrade
|
| Cash & Short-Term Investments | 12.32 | 9.5 | 6.88 | 6.99 | 6.85 | Upgrade
|
| Cash Growth | 29.61% | 38.22% | -1.65% | 2.00% | 66.82% | Upgrade
|
| Other Receivables | - | 0.28 | 0.23 | 0.91 | 1.42 | Upgrade
|
| Receivables | - | 0.28 | 0.23 | 0.91 | 1.42 | Upgrade
|
| Prepaid Expenses | 3.51 | 1.28 | 1.76 | 1.84 | 3.75 | Upgrade
|
| Other Current Assets | - | -0 | 0 | - | - | Upgrade
|
| Total Current Assets | 15.83 | 11.07 | 8.87 | 9.73 | 12.02 | Upgrade
|
| Property, Plant & Equipment | 0.19 | 0.3 | 0.2 | 0.33 | 0.21 | Upgrade
|
| Other Intangible Assets | 1.12 | 1.11 | 1.09 | 1.15 | 0.9 | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.05 | 0.06 | 0.06 | 0.05 | Upgrade
|
| Total Assets | 17.17 | 12.52 | 10.22 | 11.27 | 13.18 | Upgrade
|
| Accounts Payable | 5.55 | 4.88 | 8.97 | 6.01 | 2.23 | Upgrade
|
| Accrued Expenses | 2.93 | 1.46 | 2.4 | 2.45 | 4.06 | Upgrade
|
| Current Portion of Long-Term Debt | 10.27 | 3.72 | 3.48 | 1.85 | 0.43 | Upgrade
|
| Current Portion of Leases | 0.13 | 0.12 | 0.16 | 0.15 | 0.18 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.28 | Upgrade
|
| Total Current Liabilities | 18.87 | 10.17 | 15.01 | 10.47 | 7.18 | Upgrade
|
| Long-Term Debt | 14.2 | 8.09 | 9.42 | 11.1 | 2.92 | Upgrade
|
| Long-Term Leases | 0.08 | 0.19 | 0.05 | 0.16 | 0.02 | Upgrade
|
| Other Long-Term Liabilities | 2.53 | 3.84 | 0.9 | 1.01 | 0.15 | Upgrade
|
| Total Liabilities | 35.68 | 22.28 | 25.38 | 22.75 | 10.26 | Upgrade
|
| Common Stock | 2.69 | 2.69 | 2.69 | 2.69 | 2.69 | Upgrade
|
| Retained Earnings | -222.86 | -197.42 | -172.21 | -143.71 | -116.27 | Upgrade
|
| Comprehensive Income & Other | 201.66 | 184.97 | 154.36 | 129.55 | 116.49 | Upgrade
|
| Shareholders' Equity | -18.51 | -9.76 | -15.16 | -11.48 | 2.92 | Upgrade
|
| Total Liabilities & Equity | 17.17 | 12.52 | 10.22 | 11.27 | 13.18 | Upgrade
|
| Total Debt | 24.68 | 12.11 | 13.11 | 13.27 | 3.55 | Upgrade
|
| Net Cash (Debt) | -12.36 | -2.61 | -6.24 | -6.28 | 3.31 | Upgrade
|
| Net Cash Growth | - | - | - | - | 274.41% | Upgrade
|
| Net Cash Per Share | -0.11 | -0.03 | -0.10 | -0.11 | 0.07 | Upgrade
|
| Filing Date Shares Outstanding | 119.74 | 104.62 | 68.79 | 59.81 | 53.23 | Upgrade
|
| Total Common Shares Outstanding | 119.74 | 104.62 | 68.79 | 59.81 | 53.23 | Upgrade
|
| Working Capital | -3.05 | 0.89 | -6.14 | -0.74 | 4.85 | Upgrade
|
| Book Value Per Share | -0.15 | -0.09 | -0.22 | -0.19 | 0.05 | Upgrade
|
| Tangible Book Value | -19.62 | -10.87 | -16.25 | -12.63 | 2.02 | Upgrade
|
| Tangible Book Value Per Share | -0.16 | -0.10 | -0.24 | -0.21 | 0.04 | Upgrade
|
| Machinery | - | 0.03 | 0.03 | 0.06 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.